retatrutide clinical trial results 2024 Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a retatrutide clinical trial results 2024

The combined metabolic and CV effects of T replacement therapy and novel antidiabetic drugs are of great interest, and therefore requires further appropriately designed studies

Certain individuals may not be ideal candidates for tirzepatide treatment

Wu Z, Li X, Wen Q, Tao B, Qiu B, Zhang Q

Parker AG, Gordon J, Thornton A, et al

Does Ipamorelin raise cortisol or prolactin

While there is currently a lack of scientific data on how GLP-1 receptor agonists affect patients having surgery and interact with anesthesia, weve received anecdotal reports that the delay in stomach emptying could be associated with an increased risk of regurgitation and aspiration of food into the airways and lungs during general anesthesia and deep sedation, said ASA President Michael W